Zobrazeno 1 - 10
of 115
pro vyhledávání: '"CV disease"'
Publikováno v:
In Atherosclerosis July 2024 394
Publikováno v:
Romanian Journal of Cardiology, Vol 31, Iss 3, Pp 517-527 (2021)
Inflammation is involved in initiation, development and complications of the vast majority of non-communicable diseases. Recent research demonstrated that inflammation is involved in pathogenesis of all major cardiovascular diseases. Different endoge
Externí odkaz:
https://doaj.org/article/41414570017a4beab1c8e65f6867b1f3
Publikováno v:
In Heart, Lung and Circulation July 2020 29(7):973-987
Autor:
Mayer, Gert J. 1, Wanner, Christoph 2, Weir, Matthew R. 3, Inzucchi, Silvio E. 4, Koitka-Weber, Audrey 2, 5, 6, Hantel, Stefan 5, von Eynatten, Maximilian 5, Zinman, Bernard 7, Cherney, David Z.I. 8, ∗
Publikováno v:
In Kidney International August 2019 96(2):489-504
Autor:
Abdulrahman Ismaiel, Dan L. Dumitraşcu
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
According to the World Health Organization, cardiovascular disease (CVD) remains the leading cause of death worldwide, accounting for approximately 18 million deaths per year. Nevertheless, the worldwide prevalence of metabolic diseases, such as type
Externí odkaz:
https://doaj.org/article/821fa06d879640e0aa24685b2c09b541
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 6 (2019)
Atherosclerosis is one of the primary causes of cardiovascular disease and mortality. This chronic immunometabolic disease evolves during decades in humans and encompasses different organs and immune cell types, as well as local and systemic processe
Externí odkaz:
https://doaj.org/article/b37b95b00fb64cda898d91847e625d01
Autor:
Charytan, David M. 1, Lewis, Eldrin F. 2, Desai, Akshay S. 2, Weinrauch, Larry A. 2, Ivanovich, Peter 3, Toto, Robert D. 4, Claggett, Brian 2, Liu, Jiankang 2, Hartley, L. Howard 2, Finn, Peter 2, Singh, Ajay K. 1, Levey, Andrew S. 5, Pfeffer, Marc A. 2, McMurray, John J.V. 6, Solomon, Scott D. 2, ∗
Publikováno v:
In American Journal of Kidney Diseases September 2015 66(3):429-440
Autor:
Christoph C. Kaufmann, Amro Ahmed, Marie Muthspiel, Isabella Rostocki, Edita Pogran, David Zweiker, Achim Leo Burger, Bernhard Jäger, Gabriele Aicher, Alexander O. Spiel, Florian Vafai-Tabrizi, Michael Gschwantler, Peter Fasching, Johann Wojta, Kurt Huber
Publikováno v:
Journal of Clinical Medicine
Volume 12
Issue 3
Pages: 975
Volume 12
Issue 3
Pages: 975
Background: Excess cardiovascular (CV) morbidity and mortality has been observed in patients with COVID-19. Both interleukin-32 (IL-32) and interleukin-34 (IL-34) have been hypothesized to contribute to CV involvement in COVID-19. Methods: This prosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4676d56f5824664b876a051c9be169b6
Autor:
Dimitroulas, Theodoros a, ∗, Sandoo, Aamer a, b, Hodson, James c, Smith, Jacqueline a, Panoulas, Vasileios F. d, Kitas, George D. a, e
Publikováno v:
In Atherosclerosis November 2014 237(1):38-44
Autor:
Andreea Catarina Popescu, Serban Balanescu, Pharmacy, Bucharest, Romania, Camelia Georgescu, Elena Barbu
Publikováno v:
Romanian Journal of Cardiology, Vol 31, Iss 3, Pp 517-527 (2021)
Inflammation is involved in initiation, development and complications of the vast majority of non-communicable diseases. Recent research demonstrated that inflammation is involved in pathogenesis of all major cardiovascular diseases. Different endoge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d9a48fb5ec3839a6939ae995caf0f98
https://www.romanianjournalcardiology.ro/wp-content/uploads/2021/09/RRC_art-4.pdf
https://www.romanianjournalcardiology.ro/wp-content/uploads/2021/09/RRC_art-4.pdf